Ventum Cap Mkts Estimates Ascend Wellness Q4 Earnings

Ascend Wellness Holdings, Inc. (OTC:AAWH) – Equities research analysts at Ventum Cap Mkts issued their Q4 2024 earnings per share (EPS) estimates for Ascend Wellness in a report released on Tuesday, November 12th. Ventum Cap Mkts analyst A. Semple expects that the company will post earnings per share of ($0.07) for the quarter. The consensus estimate for Ascend Wellness’ current full-year earnings is ($0.32) per share. Ventum Cap Mkts also issued estimates for Ascend Wellness’ FY2025 earnings at ($0.26) EPS and FY2026 earnings at ($0.18) EPS.

Ascend Wellness (OTC:AAWH) last released its earnings results on Tuesday, November 12th. The company reported ($0.13) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.03). Ascend Wellness had a negative net margin of 15.47% and a negative return on equity of 66.28%. The company had revenue of $141.65 million during the quarter, compared to analyst estimates of $144.13 million.

Ascend Wellness Trading Down 10.9 %

OTC AAWH opened at $0.50 on Friday. The firm has a market cap of $106.95 million, a P/E ratio of -1.22 and a beta of 1.69. The company has a debt-to-equity ratio of 2.46, a current ratio of 2.29 and a quick ratio of 1.29. The stock’s 50-day moving average is $0.83 and its 200-day moving average is $0.96. Ascend Wellness has a one year low of $0.45 and a one year high of $1.82.

Ascend Wellness Company Profile

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.